Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
- Conditions
- CancerDementia
- Registration Number
- NCT06313853
- Lead Sponsor
- University of Rochester
- Brief Summary
Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer management (adapted intervention: COACH-Cog). The investigators hypothesize that for patients with dual diagnoses of ADRD and cancer, COACH-Cog will increase autonomy support of care partners and patients in the decision-making process, leading to greater acknowledgement and support of cognitive concerns and cognitive-related goals, thereby improving goal concordant care. The investigators are conducting a pilot randomized controlled trial (RCT; cluster randomized by physician) including approximately 45 oncology clinicians and 130 patient/care partner dyads evaluating the effect of COACH-Cog on care partner and patient autonomy support, care partner well-being, goal-concordance, and communication.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
- Be age 65 or older
- Have a clinical diagnosis of Alzheimer's disease or related dementia (ADRD [Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, or dementia of unknown subtype])
- Have a clinical diagnosis of cancer (any type or stage)
- Anticipate a potential decision about cancer-related management, as confirmed by the patient's primary medical oncology clinician.
- Have a care partner willing and able to participate in the study
- Are able to read and understand English. The communication coaching session will be delivered in English, thus necessitating this requirement.
- Be able to provide informed consent (as measured by UBACC) or have a Legally Authorized Representative to provide informed consent
Patient
Patient exclusion criteria: None
CARE PARTNER:
Care partner inclusion criteria:
- Age 18 or over
- Able to read and understand spoken English
- Able to provide informed consent
Care partner exclusion criteria:
None
ONCOLOGY CLINICIAN:
Oncology clinician inclusion criteria:
- Oncology clinicians affiliated with the Wilmot Cancer Institute
- Do not intend to move or retire within the next 2 years.
Oncology clinician exclusion criteria:
None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Care Partner: Health Care Climate Questionnaire (HCCQ) 4-weeks post oncology clinical encounter Care Partner autonomy support; score range: 6-42; higher score is better.
- Secondary Outcome Measures
Name Time Method Zarit Caregiver Burden Assessment 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter 4-Item Measure Care partner well-being: Caregiver burden; total score range 0-16; Higher score is worse burden.
Horton QOL S-subscale 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter 11-Item Measure (Subscale Measure) of Care partner well-being: Quality of Life; Total score range 0-11; higher score is worse quality of life.
Care Partner PROMIS Depression 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter Care partner well-being: Depression; score range 4-20; higher score is worse
Care partner PROMIS Anxiety 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter Care partner well-being: Anxiety; score range 4-20; higher score is worse
Care partner: Patient-Centered Communication in Cancer Care (PCC-Ca) 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter Care partner communication; score range 1-5; higher scores are better
Care partner: Health Care Climate Questionnaire - Age (HCCQ-Age) 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter Care partner Age-related autonomy support; score range 0-28; higher scores are worse
Care partner: Qualitative assessment of goal concordance 3-months post-oncology clinical encounter Care partner: Goal concordance; qualitative analysis if goal concordance occurred (yes/no); range 0-130; higher number better
Care partner: Decision Regret Scale 3-months post-oncology clinical encounter Care partner: Decision regret; score range 5-25; higher score is worse
Trial Locations
- Locations (1)
University of Rochester Wilmot Cancer Institute
🇺🇸Rochester, New York, United States
University of Rochester Wilmot Cancer Institute🇺🇸Rochester, New York, United StatesAllison Magnuson, DO, MSContactAllison_magnuson@urmc.rochester.eduJessica BauerContactJessicaC_Bauer@URMC.Rochester.edu